Breaking News

PharmaEssentia to Establish a Manufacturing Subsidiary in Puerto Rico

The planned $46 million investment is intended to serve as a future manufacturing center for the U.S. market.

Author Image

By: Charlie Sternberg

Associate Editor

PharmaEssentia Corporation, a global biopharmaceutical company headquartered in Taiwan, will invest approximately $46 million to establish a new, wholly owned manufacturing subsidiary in Puerto Rico. The planned investment supports the company’s global manufacturing expansion strategy and is intended to serve as a future manufacturing center for the U.S. market and long-term global demand for BESREMi (ropeginterferon alfa-2b). The investment reflects sustained global demand growth for BESR...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters